Cardiac Risk the Same With All Sulfonylureas in Diabetes Cardiac Risk the Same With All Sulfonylureas in Diabetes

There is no difference in cardiac risk between nonspecific, long-acting sulfonylureas and specific, short-acting agents, although the former are more likely to provoke severe hypoglycemia.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news